Revisiting Treatment Options for Depressed Patients with Generalised Anxiety Disorder
Open Access
- 21 August 2021
- journal article
- review article
- Published by Springer Nature in Advances in Therapy
- Vol. 38 (S2) , 61-68
Abstract
Symptoms of anxiety and depression often coexist, and evidence suggests that this has a genetic basis, among other possible causes. However, the current classification of comorbid generalised anxiety disorder (GAD) and depression (anxious depression) in the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition; DSM-5) does not fully reflect the high prevalence of anxiety symptoms in people with depression and the International Classification of Diseases (10th and 11th revisions) has tended to identify anxious depression with minor disorders seen in primary care. As a result, few dedicated therapeutic trials have been conducted in patients with anxious depression, and specific treatment guidelines and recommendations are lacking. Fortunately, there is considerable therapeutic overlap between anxiety and depression, such that many agents with antidepressant efficacy are also effective for symptoms of GAD. The initial treatment of a patient with depression and symptoms of anxiety should be with an agent that is approved for both major depressive disorder and GAD, such as a selective serotonin reuptake inhibitor. There is an obvious need for greater recognition of anxious depression in order to boost the volume of high-quality clinical data, which should translate over time into better, more specific treatment recommendations and improved outcomes.Keywords
Funding Information
- Servier
This publication has 21 references indexed in Scilit:
- Patients with anxious depressionCurrent Opinion in Psychiatry, 2018
- Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorderScientific Reports, 2017
- A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptomsJournal of Affective Disorders, 2016
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive DisorderThe Canadian Journal of Psychiatry, 2016
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive DisorderThe Canadian Journal of Psychiatry, 2016
- The relevance of ‘mixed anxiety and depression’ as a diagnostic category in clinical practiceEuropean Archives of Psychiatry and Clinical Neuroscience, 2016
- The prevalence and clinical characteristics associated with Diagnostic and Statistical Manual Version-5-defined anxious distress specifier in adults with major depressive disorder: results from the International Mood Disorders Collaborative ProjectTherapeutic Advances in Chronic Disease, 2016
- Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelinesJournal of Psychopharmacology, 2015
- Efficacy of Bupropion and the Selective Serotonin Reuptake Inhibitors in the Treatment of Major Depressive Disorder With High Levels of Anxiety (Anxious Depression)The Journal of Clinical Psychiatry, 2008
- Major depression and generalised anxiety disorder. Same genes, (partly)different environments--revisited.1996